Crucell N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
10 feb 2009 - 07:44
Statutaire naam
Crucell N.V.
Titel
DSM and Crucell Sign Agreement with Bioceros to Serve as Pre-Approved Cell Line Generation Partner of PER.C6® Cell Line Proteins
Bericht
Leiden, The Netherlands/Parsippany, USA, 10 February 2009 – DSM
Biologics and Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX)
announced today that they have entered into an agreement with Bioceros B.V. of
Utrecht, The Netherlands to join their Vendor Network. Under the terms of the
agreement, Bioceros will be a pre-approved cell line generation partner for
licensees of the PER.C6® cell line located in the European Union.
Karen King, president of DSM Biologics notes, "The growing number of PER.C6®
licensees requires that we expand the possibilities for our licensees to obtain
services like cell line generation. We are confident that Bioceros’ excellent
experience and service level will provide our European licensees additional
options to move their PER.C6® programs forward successfully."
Datum laatste update: 18 december 2025